ArticleNaunyn-Schmiedeberg's archives of pharmacology2025
Exploring the impact of cuproptosis-related genes on immune infiltration in rheumatoid arthritis.
Article in Naunyn-Schmiedeberg's archives of pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Research Progress of Cuproptosis in Orthopaedics: Opportunities and Challenges.Journal of cellular and molecular medicine · 2026Review
- Cuproptosis in inflammation and cancer: molecular mechanisms and therapeutic targets.Molecular cancer · 2026Review
- Elevated miR-409-5p may promote the progression of osteoarthritis by targeting DLST as a potential biomarker function of miR-409-5p in osteoarthritis.Journal of orthopaedic surgery and research · 2026Article
- Cuproptosis and its potential role in musculoskeletal disease.Frontiers in cell and developmental biology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Immune infiltration plays a significant role in the pathogenesis of rheumatoid arthritis (RA). Cuproptosis, a newly characterized form of programmed cell death, remains insufficiently investigated regarding its genetic regulation of immune infiltration in RA. Data from the GEO database were analyzed to determine the relationship between cuproptosis-related genes and immune infiltration. Comprehensive analyses, including Gene Ontology, and KEGG pathway enrichment were performed to construct a risk model and provide a theoretical framework for understanding the mechanisms underlying the involvement of cuproptosis in RA-related immune infiltration. And we explored the expression of related genes-PDHB in animal and cell experiments. The findings revealed substantial variations in immune infiltration between RA and control groups. Eleven cuproptosis-related genes associated with RA were identified, namely DLST, LIAS, DLAT, DLD, PDHB, Lipt1, DBT, ATP7B, SLC31A1, FDX1, and PDHA1. Among these, DLST and PDHB emerged as potential risk factors influencing RA pathogenesis. These genes modulated immune cell alterations, including changes in iDCs, NK-cells, mast cells, and pDCs, alongside impacts on immune functions specific to RA. In animal experiments, we found that the expression of PDHB is decreased; overexpression of PDHB by PDHB gene transfection inhibited the migration, invasion, and proliferation of FLS cells.
Indexed as
Identifiers
39800811What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.